GMEX Robotics (GMEX) Q4 2024 earnings summary

Executive summary

• Revenue decreased 6.9% year-over-year to $4.47M, with gross profit margin dropping to 35.5% from 45.3% due to strategic price reductions and higher logistics costs.

• Net loss widened to $9.3M from $1.6M, driven by one-off consulting fees, increased G&A expenses, and a debt discount related to convertible notes.

• Normalized net loss, excluding extraordinary items, was $2.4M, up 353% year-over-year.

• IPO in August 2023 raised $13.6M; a $3.6M convertible note and warrants were issued and fully converted in early 2024.

• The company faces substantial doubt about its ability to continue as a going concern due to ongoing losses and negative cash flow from operations.

Financial highlights

• Merchandise revenue fell 2% to $4.0M; licensing revenue dropped 72% to $151K; consumables sales rose 60.5% to $359K.

• Cost of goods sold increased 9.7% to $2.88M, reflecting higher sales volume but lower average order value.

• Operating expenses surged to $9.6M (215% of revenue), mainly due to $5.5M in one-time consulting fees and $798K R&D for mobile app.

• Interest expense rose to $1.24M, including a $1.1M debt discount from convertible notes.

• Cash and equivalents at year-end were $939K, with $2.5M in note receivables and $13.6M raised from the IPO.

Outlook and guidance

• Management expects to expand smart connected equipment and digital fitness programs, with commercial launches planned for late 2024.

• Plans to grow licensing business in Asia-Pacific and develop private-label cardio equipment and health supplements.

• Cautious on near-term revenue growth due to inflation, high interest rates, and weak consumer sentiment in Australia.